跳至主要内容
临床试验/NL-OMON39725
NL-OMON39725已完成4 期

Effects of prophylactic use of haloperidol in critically ill patients with a high risk for delirium - Delirium_Haldol-prophy

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 1,789 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
1,789

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • All consecutive ICU patients:;- age >= 18 year;- expected length of ICU stay of over one day

排除标准

  • - history of epilepsy, Parkinson*s disease, hypokinetic rigid syndrome, dementia or alcohol abuse
  • - patients admitted to the ICU for neurological reasons
  • - patients treated with other anti-psychotics
  • - prolonged QTc-time (over 500msec) or history of ventricular arrhythmia (in last 12 months)
  • - pregnancy
  • - delirious before ICU admission
  • - serious auditory or visual disorders
  • - ICU-stay <=1 day;- unable to understand Dutch
  • - severely mentally disabled
  • - serious receptive aphasia
  • - allergic to haloperidol
  • - moribund and not expected to survive 2 days

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验